CareHub Neurology Guide4 min read

Meningitis

Clinical guidelines for managing meningeal inflammation, analyzing cerebrospinal fluid parameters, and evaluating rapid antibiotic and steroid protocols.

OpenPHR Flagship Deep-Dive Product
Explore our Flagship Parkinson's Disease Hub (Live Clinical Trials, DBS & DaTscan Price Spreads & Medicare Guide)
Start with Parkinson's

🧠 Standard of Care & Symptoms

Meningitis is an acute inflammation of the protective membranes (meninges) covering the brain and spinal cord, representing a medical emergency when bacterial pathogens are involved.

  • Presentation: The classic clinical triad consists of **fever**, **altered mental status** (confusion, lethargy), and **nuchal rigidity** (neck stiffness preventing passive chin-to-chest flexion). Other symptoms include severe headache, photophobia (sensitivity to light), phonophobia (sensitivity to sound), and a petechial/purpuric rash (suggestive of meningococcemia).
    • Kernig's Sign: Severe stiffness in the hamstrings causing pain and resistance when the hip is flexed to 90 degrees and the knee is passively extended.
    • Brudzinski's Sign: Passive flexion of the neck automatically triggers involuntary flexion of the hips and knees.
  • Etiology:
    • Bacterial: Most severe. Common pathogens include **Streptococcus pneumoniae**, **Neisseria meningitidis** (meningococcus), and **Haemophilus influenzae**. In neonates and elderly patients (> 50 years), **Listeria monocytogenes** must be considered.
    • Viral: Less severe, usually self-limiting. Caused by enteroviruses, herpes simplex virus (HSV-2), and mumps.

🧬 Diagnostics & Lumbar Puncture

Immediate cerebrospinal fluid (CSF) analysis via a lumbar puncture (LP) is the definitive diagnostic step.

CSF Parameter Differentiation

Parameter Normal Bacterial Meningitis Viral Meningitis
Opening Pressure 90-180 mm H₂O Elevated (>200) Normal / Mildly Elevated
WBC Count < 5 / mm³ Markedly Elevated (1,000-10,000+) Elevated (10-500)
WBC Predominance Lymphocytes Neutrophils (> 80%) Lymphocytes (> 50%)
Protein 15-45 mg/dL Elevated (>100-500+) Normal / Mildly Elevated
Glucose 40-70 mg/dL Decreased (<40 or Ratio <0.4) Normal
CT Scan Rule: In patients with papilledema, history of CNS disease, focal neurological deficits, new-onset seizures, or severe immunocompromised state, perform a **head CT before lumbar puncture** to rule out mass lesions and prevent fatal brain herniation.

Microbiological & Molecular Testing

  • Gram Stain: Provides rapid presumptive identification. Streptococcus pneumoniae appears as **Gram-positive, lancet-shaped diplococci**; Neisseria meningitidis as **Gram-negative, kidney bean-shaped diplococci**; and Haemophilus influenzae as small **Gram-negative coccobacilli**.
  • Multiplex Real-Time PCR: Extremely high sensitivity and specificity. Detects nucleic acids of common bacterial (pneumococcus, meningococcus, Listeria) and viral (enterovirus, HSV-1/2, VZV) pathogens directly from CSF within 1 to 2 hours, even after antibiotics have been started.
  • Latex Agglutination: Rapidly detects bacterial capsular polysaccharides in the CSF, particularly useful if the patient received prior antibiotics that prevent bacterial growth in culture.

💊 Antibiotics & Dexamethasone Protocols

Empiric treatment must be initiated immediately after blood cultures are drawn and before the spinal tap is performed if delays occur.

Standard Empiric Regimen

  • Broad-Spectrum Antibiotics:
    • Ceftriaxone (2g IV every 12 hours) + Vancomycin (15-20 mg/kg IV): Targets cephalosporin-resistant S. pneumoniae and N. meningitidis.
    • Ampicillin (2g IV every 4 hours): Added to the empiric regimen for patients **under 3 months or over 50 years** (and immunocompromised patients) to cover Listeria monocytogenes.
  • Adjunctive Corticosteroids (Dexamethasone 10mg IV): Highly critical. Must be administered **before or with the first dose of antibiotics**. Dexamethasone inhibits the massive release of inflammatory cytokines triggered by bacterial lysis, significantly reducing rates of hearing loss, focal deficits, and mortality in S. pneumoniae meningitis. Discontinue if culture reveals non-bacterial cause.

🔬 Active Clinical Trials

Clinical trials are evaluating ultra-rapid multiplex PCR cerebrospinal fluid assays, novel selective intracranial pressure reduction devices, and vaccine efficacy targeting emerging meningococcal serogroups.

NCT06922389: Bedside Multiplex PCR Pathogen Detection Panel

A Phase III clinical trial validating a next-generation 15-minute multiplex PCR panel for immediate bedside CSF pathogen detection.

Key Inclusion: Age ≥ 1 month, presenting with clinical signs of acute meningitis (fever, nuchal rigidity), and undergoing diagnostic lumbar puncture.
NCT07050077: Adjunctive Selective Anti-Inflammatory Peptide

Testing an adjunctive selective anti-inflammatory peptide to reduce meningeal inflammation without compromising antibiotic bacterial clearance.

Key Inclusion: Age 18 to 65, laboratory-confirmed bacterial meningitis (CSF neutrophils ≥ 80%, CSF glucose < 40 mg/dL), and administered within 24 hours of first antibiotic dose.
NCT07118600: Post-Meningitis Cognitive Outcomes and Neuro-Rehabilitation

A multi-center study evaluating long-term cognitive outcomes in adults following bacterial meningitis.

Key Inclusion: Age ≥ 18, documented history of bacterial meningitis survived within the past 12 months, and experiencing persistent cognitive complaints.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

🗺️ Next Steps After Diagnosis

If you or a family member has recently survived an episode of acute meningitis, establish these follow-up procedures:

  1. Schedule a Audiometry (Hearing) Evaluation: Post-meningitis hearing loss is common due to inflammatory damage to the cochlea. Obtain an audiogram within 4 to 6 weeks of discharge.
  2. Administer Contact Prophylaxis: If the patient was diagnosed with Neisseria meningitidis, close household contacts and healthcare workers exposed to secretions must receive immediate chemoprophylaxis with **Rifampin**, **Ciprofloxacin**, or **Ceftriaxone**.
  3. Verify Vaccination Deficiencies: Ensure completion of S. pneumoniae (PCV20) and N. meningitidis (MenACWY and MenB) vaccine schedules once recovered.
  4. Address Cognitive After-Effects: Many survivors experience transient fatigue, memory difficulty, and concentration issues. Coordinate with a neuropsychologist for cognitive rehabilitation if symptoms persist.

❓ Patient FAQ

Q: What is "aseptic meningitis"?
A: Aseptic meningitis refers to cases of meningitis where standard bacterial cultures are negative. It is most commonly caused by viruses (such as enteroviruses), but can also be caused by drugs (drug-induced aseptic meningitis), autoimmune diseases (lupus), or atypical organisms (Lyme disease, tuberculosis).

Q: Why is bacterial meningitis considered so urgent?
A: Bacterial replication in the subarachnoid space triggers rapid, intense inflammation. This leads to swelling of the brain tissue (cerebral edema), elevated intracranial pressure, and reduced cerebral blood flow, which can cause permanent brain damage, hearing loss, or death within hours if antibiotics are not immediately administered.

Back to All 128 CareHub Condition GuidesFor informational purposes only • Always consult a physician